Myriad Genetics (MYGN)
Myriad Genetics (MYGN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- MYGN last traded at $5.36 on 2026-11-20, -3.25% for the session.
- Myriad Genetics: market cap $514.14M, revenue $803.60M over the last four quarters.
- Over the past year MYGN returned -16.77%, with a year-to-date return of -12.85%.